OTCQX:MRVFF - Post by User
Post by
semanticalityon Jan 22, 2015 7:33pm
636 Views
Post# 23353855
IR Response to NASDAQ Listing Inquiry
IR Response to NASDAQ Listing Inquiry Info <info@nuvoresearch.com> | | | | |
|
Assuming positive data from the Phase 2 WF10 Allergic Rhinitis study, we plan to seek a NASDAQ listing in 2015. Our 2015 IR priority is to expand our US shareholder base. That strategy includes securing a partnership with a US investment bank(s), US analyst coverage, non-deal road shows and a NASDAQ listing. We do not yet have a specific target date for the listing.
Contingent on Phase 2. Hopefully the recent SP increase is indicative of forthcoming positive results. We'll know soon enough GLTA